Biosytes, Inc. was awarded United States Patent 6,056,971 for the Bio-Solv process used to enhance the bioavailability and absorption of Coenzyme Q10. 

Tishcon Corporation, Westbury, NY has the exclusive worldwide rights to the patented process. The Bio-Solv process is used in Tishcon’s Q-Gel Coenzyme Q10 formulas. It improves absorption by making CoQ10 virtually water soluble (hydrosoluble) and by reducing its particle size. Human clinical studies have shown that the Bio-Solv process used in the Q-Gel formulation makes CoQ10 several times more bioavailable than conventional supplement forms.